Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Davis

Showing results (131-140 of 505) with videos related to

Pageof 51
Sort By:
Schizophrenia Research|March 21, 2015
Joint modeling of dropout and outcome in three pivotal clinical trials of schizophreniaStephen Z Levine, Yair Goldberg, Myrto Samara, et al.
The International Journal of Neuropsychopharmacology|October 16, 2004
Serotonergic antidepressant effects on aggressive, self-injurious and destructive/disruptive behaviours in intellectually disabled adults: a retrospective, open-label, naturalistic trialDavid S Janowsky, Mahesh Shetty, Jarrett Barnhill, et al.
Epidemiology (Cambridge, Mass.)|March 18, 2009
High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fishJean Golding, Colin Steer, Pauline Emmett, et al.
Medicine|July 13, 2005
Clinical features of 39 patients with antibodies to extractable nuclear antigens despite negative antinuclear antibodies: evidence for autoimmunity including neurologic and connective tissue diseasesJohn M Davis, Kevin G Moder, Henry A Homburger, et al.
The British Journal of Nutrition|December 2, 2010
n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trialsChristopher E Ramsden, Joseph R Hibbeln, Sharon F Majchrzak, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 29, 2014
Chlorpromazine versus every other antipsychotic for schizophrenia: a systematic review and meta-analysis challenging the dogma of equal efficacy of antipsychotic drugsMyrto T Samara, Haoyin Cao, Bartosz Helfer, et al.
The Journal of Rheumatology|May 15, 2023
Avoiding Blunders When Analyzing Correlated Data, Clustered Data, or Repeated MeasuresYu-Hui H Chang, Matthew R Buras, John M Davis, et al.
Schizophrenia Research. Cognition|June 16, 2025
Cognitive changes in schizophrenia before and after illness onset: A meta-analysis examining consistency in measurement tools as a moderatorNoaz Cohen, Mark Weiser, Abraham Reichenberg, et al.
Science Advances|September 1, 2023
<i>Eggerthella lenta</i> augments preclinical autoantibody production and metabolic shift mimicking senescence in arthritisBaskar Balakrishnan, David Luckey, Kerry Wright, et al.
Arthritis and Rheumatism|September 5, 2002
Bullous skin lesions following infliximab infusion in a patient with rheumatoid arthritisPeter D Kent, John M Davis, Mark D P Davis, et al.
Pageof 51

Showing results (131-140 of 505) with videos related to

Sort By:
Pageof 51
Schizophrenia Research|March 21, 2015
Joint modeling of dropout and outcome in three pivotal clinical trials of schizophreniaStephen Z Levine, Yair Goldberg, Myrto Samara, et al.
The International Journal of Neuropsychopharmacology|October 16, 2004
Serotonergic antidepressant effects on aggressive, self-injurious and destructive/disruptive behaviours in intellectually disabled adults: a retrospective, open-label, naturalistic trialDavid S Janowsky, Mahesh Shetty, Jarrett Barnhill, et al.
Epidemiology (Cambridge, Mass.)|March 18, 2009
High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fishJean Golding, Colin Steer, Pauline Emmett, et al.
Medicine|July 13, 2005
Clinical features of 39 patients with antibodies to extractable nuclear antigens despite negative antinuclear antibodies: evidence for autoimmunity including neurologic and connective tissue diseasesJohn M Davis, Kevin G Moder, Henry A Homburger, et al.
The British Journal of Nutrition|December 2, 2010
n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trialsChristopher E Ramsden, Joseph R Hibbeln, Sharon F Majchrzak, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 29, 2014
Chlorpromazine versus every other antipsychotic for schizophrenia: a systematic review and meta-analysis challenging the dogma of equal efficacy of antipsychotic drugsMyrto T Samara, Haoyin Cao, Bartosz Helfer, et al.
The Journal of Rheumatology|May 15, 2023
Avoiding Blunders When Analyzing Correlated Data, Clustered Data, or Repeated MeasuresYu-Hui H Chang, Matthew R Buras, John M Davis, et al.
Schizophrenia Research. Cognition|June 16, 2025
Cognitive changes in schizophrenia before and after illness onset: A meta-analysis examining consistency in measurement tools as a moderatorNoaz Cohen, Mark Weiser, Abraham Reichenberg, et al.
Science Advances|September 1, 2023
<i>Eggerthella lenta</i> augments preclinical autoantibody production and metabolic shift mimicking senescence in arthritisBaskar Balakrishnan, David Luckey, Kerry Wright, et al.
Arthritis and Rheumatism|September 5, 2002
Bullous skin lesions following infliximab infusion in a patient with rheumatoid arthritisPeter D Kent, John M Davis, Mark D P Davis, et al.
Pageof 51